JP2016500073A5 - - Google Patents

Download PDF

Info

Publication number
JP2016500073A5
JP2016500073A5 JP2015543098A JP2015543098A JP2016500073A5 JP 2016500073 A5 JP2016500073 A5 JP 2016500073A5 JP 2015543098 A JP2015543098 A JP 2015543098A JP 2015543098 A JP2015543098 A JP 2015543098A JP 2016500073 A5 JP2016500073 A5 JP 2016500073A5
Authority
JP
Japan
Prior art keywords
carboxamide
pyrazine
methyl
imidazo
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015543098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/070623 external-priority patent/WO2014078813A1/en
Publication of JP2016500073A publication Critical patent/JP2016500073A/ja
Publication of JP2016500073A5 publication Critical patent/JP2016500073A5/ja
Pending legal-status Critical Current

Links

JP2015543098A 2012-11-19 2013-11-18 寄生虫病の処置のための化合物および組成物 Pending JP2016500073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261728024P 2012-11-19 2012-11-19
US61/728,024 2012-11-19
PCT/US2013/070623 WO2014078813A1 (en) 2012-11-19 2013-11-18 Compounds and compositions for the treatment of parasitic diseases

Publications (2)

Publication Number Publication Date
JP2016500073A JP2016500073A (ja) 2016-01-07
JP2016500073A5 true JP2016500073A5 (https=) 2016-12-28

Family

ID=49667633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015543098A Pending JP2016500073A (ja) 2012-11-19 2013-11-18 寄生虫病の処置のための化合物および組成物

Country Status (5)

Country Link
US (1) US20150291598A1 (https=)
EP (1) EP2920177A1 (https=)
JP (1) JP2016500073A (https=)
CN (1) CN105189506A (https=)
WO (1) WO2014078813A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014078813A1 (en) * 2012-11-19 2014-05-22 Irm Llc Compounds and compositions for the treatment of parasitic diseases
CN105164124B (zh) 2012-11-19 2017-03-15 诺华股份有限公司 用于治疗寄生虫疾病的化合物和组合物
RU2725979C2 (ru) * 2014-06-25 2020-07-08 Ф. Хоффманн-Ля Рош Аг ИМИДАЗО[1,2-а]ПИРАЗИН-1-ИЛ-БЕНЗАМИДЫ ДЛЯ ЛЕЧЕНИЯ СПИНАЛЬНОЙ МЫШЕЧНОЙ АТРОФИИ
CA2969090C (en) 2014-12-23 2023-05-02 Novartis Ag Triazolopyrimidine compounds and uses thereof
CN104610229B (zh) * 2015-01-21 2017-01-18 上海皓元生物医药科技有限公司 一种是atp竞争性小分子akt抑制剂a443654的合成方法
JP7042812B2 (ja) 2016-06-20 2022-03-28 ノバルティス アーゲー トリアゾロピリミジン化合物の結晶形態
WO2017221100A1 (en) 2016-06-20 2017-12-28 Novartis Ag Imidazopyrimidine compounds useful for the treatment of cancer
WO2017221092A1 (en) 2016-06-20 2017-12-28 Novartis Ag Triazolopyridine compounds and uses thereof
GB201700692D0 (en) * 2017-01-16 2017-03-01 Salvensis Novel compounds and their use in the treatment of schistosomiasis
EP3617207B1 (en) * 2017-04-27 2023-06-28 Nihon Nohyaku Co., Ltd. Condensed heterocyclic compound or salt thereof, agricultural and horticultural insecticide comprising the compound or the salt, and method for using the insecticide
US11584744B2 (en) * 2017-06-23 2023-02-21 University Of Washington Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them
JP2020525472A (ja) * 2017-06-30 2020-08-27 ライブ・セラピューティクス・スプウカ・アクツィーナRyvu Therapeutics S.A. アデノシンa2a受容体のイミダゾ[1,2−a]ピラジン調節剤
CN110168093B (zh) * 2017-09-12 2023-08-15 中科蓝华(广州)生物医药技术有限公司 一种转染细胞内寄生虫的试剂盒及其应用
EP3746071A4 (en) 2018-01-29 2021-09-01 Merck Patent GmbH GCN2 INHIBITORS AND THEIR USES
US10239885B1 (en) 2018-06-18 2019-03-26 Avista Pharma Solutions, Inc. Compound 1-[2-[4-(2-ethyl-6,8-dimethylimidazo[1,2-α]pyrazin-3-yl)phenyl]ethyl]-3-(p-tolylsulfonyl)urea as a prostaglandin EP4 receptor antagonist
GB201811695D0 (en) * 2018-07-17 2018-08-29 Salvensis Compounds for use in the treatment of fascioliasis
SG11202012616RA (en) 2018-08-21 2021-02-25 Kyorin Pharmaceutical Co Ltd Bicyclic heteroaromatic ring derivative
AU2019395201A1 (en) 2018-12-06 2021-05-20 Daiichi Sankyo Company, Limited Cycloalkane-1,3-diamine derivative
US11512088B2 (en) 2019-01-30 2022-11-29 Avista Pharma Solutions, Inc. Synthetic process and intermediates
WO2020160075A1 (en) 2019-01-30 2020-08-06 Avista Pharma Solutions, Inc. Chemical compounds
BR112022007404A2 (pt) 2019-10-21 2022-07-05 Novartis Ag Compostos e composições para o tratamento de doenças parasíticas
WO2024022910A1 (en) 2022-07-26 2024-02-01 Syngenta Crop Protection Ag 1-[1-[2-(pyrimidin-4-yl)-1,2,4-triazol-3-yl]ethyl]-3-[2,4-dichloro-5-phenyl]urea derivatives and similar compounds as pesticides
EP4695245A1 (en) * 2023-04-13 2026-02-18 Syngenta Crop Protection AG Imidazo[1,2-a]pyridine derivatives
PY2426847A (es) * 2023-04-13 2025-03-20 Syngenta Crop Protection Ag Derivados bicíclicos de imidazo
TW202446263A (zh) * 2023-04-13 2024-12-01 瑞士商先正達農作物保護股份公司 殺真菌組成物
WO2024213653A1 (en) * 2023-04-13 2024-10-17 Syngenta Crop Protection Ag Imidazo[1,2-a]pyridine derivatives
AR132352A1 (es) * 2023-04-13 2025-06-18 Syngenta Crop Protection Ag Derivados de imidazo[1,2-a]pirazina
WO2024213650A1 (en) * 2023-04-13 2024-10-17 Syngenta Crop Protection Ag Imidazo[1,2-a]pyridine derivatives
WO2026018203A1 (en) * 2024-07-19 2026-01-22 Novartis Ag Aminoisoquinoline compounds and methods of using thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
CN101622001A (zh) * 2007-01-26 2010-01-06 Irm责任有限公司 作为激酶抑制剂用于治疗疟原虫相关疾病的嘌呤化合物和组合物
TWI421252B (zh) * 2009-07-09 2014-01-01 Irm Llc 用於治療寄生蟲疾病之化合物及組合物
WO2014078813A1 (en) * 2012-11-19 2014-05-22 Irm Llc Compounds and compositions for the treatment of parasitic diseases

Similar Documents

Publication Publication Date Title
JP2016500073A5 (https=)
US11591336B2 (en) Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
ES2968796T3 (es) Derivados de tiadiazolilo como inhibidores de la ADN polimerasa theta
JP5864589B2 (ja) 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類
JP2015522002A5 (https=)
JP2017530960A5 (https=)
RU2017105296A (ru) Новые соединения
JP2013508404A5 (https=)
JP2020527560A5 (https=)
JP2020514267A5 (https=)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2017510576A5 (https=)
RU2016124178A (ru) Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
JP2017520607A (ja) 置換尿素誘導体及びその薬学的使用
JP2016500073A (ja) 寄生虫病の処置のための化合物および組成物
JP2016519096A5 (https=)
CN111868037B (zh) 作为crhr2拮抗剂的稠合环状脲衍生物
JP2016507551A5 (https=)
JP2014511355A5 (https=)
IL310330A (en) Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling
WO2017102091A1 (en) Heteroarylbenzimidazole compounds
US20250230155A1 (en) 7,8-dihydro-5h-1,6-naphthyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 for treating neurological and psychiatric disorders
JPWO2020052631A5 (https=)
AU2023305453A1 (en) Tyrosine kinase 2 inhibitors and uses thereof
JPWO2019198692A5 (https=)